<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">fcmedicine</journal-id><journal-title-group><journal-title xml:lang="ru">Фундаментальная и клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Fundamental and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-0764</issn><issn pub-type="epub">2542-0941</issn><publisher><publisher-name>КемГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23946/2500-0764-2019-4-2-72-77</article-id><article-id custom-type="elpub" pub-id-type="custom">fcmedicine-145</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Популяционно-генетическое исследование полиморфизма гена VDR</article-title><trans-title-group xml:lang="en"><trans-title>Population-genetic research of the VDR gene polymorphism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1169-715X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волков</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Волков Алексей Николаевич - кандидат биологических наук, доцент кафедры биологии с основами генетики и паразитологии; старший научный сотрудник Центральной научно-исследовательской лаборатории.</p><p>650056, Кемерово, ул. Ворошилова, д. 22а</p></bio><bio xml:lang="en"><p>Dr. Alexey N. Volkov - PhD, Associate Professor, Department of Biology, Genetics and Parasitology; Senior Researcher, Central Research Laboratory.</p><p>22a, Voroshilova Street, Kemerovo, 650056</p></bio><email xlink:type="simple">volkov_alex@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6268-6242</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цуркан</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsurkan</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цуркан Елена Владимировна - биолог медико-генетической консультации</p></bio><bio xml:lang="en"><p>Dr. Elena V. Tsurkan - MD, Biologist, Unitfor Genetic Counseling.</p><p>22, Oktyabrskiy Prospekt, Kemerovo, 650061</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУВО «Кемеровский государственный медицинскийуниверситет» Министерства здравоохранения Российской Федерации; ГАУЗ КО Кемеровская областная клиническая больница им. С.В. Беляева</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kemerovo State Medical University; Kemerovo Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГАУЗ КО Кемеровская областная клиническая больница им. С.В. Беляева</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kemerovo Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2019</year></pub-date><volume>4</volume><issue>2</issue><fpage>72</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Волков А.Н., Цуркан Е.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Волков А.Н., Цуркан Е.В.</copyright-holder><copyright-holder xml:lang="en">Volkov A.N., Tsurkan E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://fcm.kemsmu.ru/jour/article/view/145">https://fcm.kemsmu.ru/jour/article/view/145</self-uri><abstract><sec><title>Цель</title><p>Цель.Установление частоты аллелей и генотипов полиморфного маркера BsmI (rsl544410) гена VDR в выборке жителей Кемеровской области.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено генотипи-рование маркера rsl544410 гена VDR у 232 человек (125 мужчин и 107 женщин), проживающих на территории Кемеровской области. Возраст обследованных варьировал в пределах 45 - 74 года при среднем значении 58,3 ± 1,86 года. Из цельной крови термокоагуляционным методом выделяли ДНК. Полученные образцы ДНК использовали для проведения аллель-специфической амплификации rsl544410. Рассчитывались частоты аллелей и генотипов изучаемого маркера.</p></sec><sec><title>Результаты</title><p>Результаты. Преобладающим генотипом маркера rsl544410 в изученной выборке был гетерозиготный вариант G/А с частотой 46,1%. Частота гомозиготного генотипа AJA, предрасполагающего к снижению минеральной плотности кости и остеопорозу, достигла 13,8%. Доля соответствующего аллеля А составила 36,9%. Соотношение генотипов rsl544410 было сопоставимо с распределениями, характерными для этнически близких народностей.</p></sec><sec><title>Заключение</title><p>Заключение. Высокая частота генотипа, предрасполагающего к снижению минерализации костной ткани, может являться одним из факторов, определяющих широкую распространенность остеопороза и сопутствующих заболеваний.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To explore the prevalence of alleles and genotypes in rsl544410 polymorphism within the VDR gene in the population of Kemerovo Region.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. Genotyping was performed in 232 residents of Kemerovo region (125 men and 107 women, average 58,3 ± 1,86 (range 45-74) years of age). DNA was extracted from the peripheral blood utilizing a thermocoagulation method while genotyping was carried out by allele-specific polymerase chain reaction.</p></sec><sec><title>Results</title><p>Results. Heterozygous (G/A)    rsl544410 genotype prevailed in the studied sample (46.1%). Homozygous genotype A/A associated with the reduced bone mineral density and osteopenia/osteoporosis was defined in 13.8% of individuals. The ratio of rsl544410 genotypes was comparable with that of ethnically close populations.</p></sec><sec><title>Conclusion</title><p>Conclusion. High population frequency of the A/A genotype of the rsl544410 polymorphism within the VDR gene may be one of the factors determining the high prevalence of osteoporosis in the population of Kemerovo Region.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>молекулярно-генетическая диагностика</kwd><kwd>VDR</kwd><kwd>минеральная плотность кости</kwd><kwd>остеопороз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>molecular genetic diagnostics</kwd><kwd>VDR</kwd><kwd>bone mineral density</kwd><kwd>osteoporosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis. Clin Ther. 2015; 37 (8): 1837-1850. doi: 10.1016/j.clinthera.2015.06.006.</mixed-citation><mixed-citation xml:lang="en">Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis. Clin Ther. 2015; 37 (8): 1837-1850. doi: 10.1016/j.clinthera.2015.06.006.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Gen Dev. 2006; 20 (18): 2492-2506. doi: 10.1101/gad.l449506.</mixed-citation><mixed-citation xml:lang="en">Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Gen Dev. 2006; 20 (18): 2492-2506. doi: 10.1101/gad.l449506.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshida T, Stern PH. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012; 41 (3): 557-569. doi: 10.1016/j.ecl.2012.04.003.</mixed-citation><mixed-citation xml:lang="en">Yoshida T, Stern PH. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012; 41 (3): 557-569. doi: 10.1016/j.ecl.2012.04.003.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012; 12 (6): 528-547. doi: 10.2174/156802612799436623.</mixed-citation><mixed-citation xml:lang="en">Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012; 12 (6): 528-547. doi: 10.2174/156802612799436623.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Laird E, Ward M, McSorley E, Strain JJ, Wallace J. Vitamin D and bone health; potential mechanisms. Nutrients. 2010; 2 (7): 693-724. doi: 10.3390/nu2070693.</mixed-citation><mixed-citation xml:lang="en">Laird E, Ward M, McSorley E, Strain JJ, Wallace J. Vitamin D and bone health; potential mechanisms. Nutrients. 2010; 2 (7): 693-724. doi: 10.3390/nu2070693.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Xi B, Li K, Wang C. Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women. Mol Biol Rep. 2012; 39 (5): 5709-5717. doi: 10.1007/sll033-011-1380-3.</mixed-citation><mixed-citation xml:lang="en">Li Y, Xi B, Li K, Wang C. Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women. Mol Biol Rep. 2012; 39 (5): 5709-5717. doi: 10.1007/sll033-011-1380-3.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pouresmaeili F, Jamshidi J, Azargashb E, Samangouee S. Association between vitamin D receptor gene BsmI polymorphism and bone mineral density in a population of 146 Iranian women. Cell J. 2013; 15 (1): 75-82.</mixed-citation><mixed-citation xml:lang="en">Pouresmaeili F, Jamshidi J, Azargashb E, Samangouee S. Association between vitamin D receptor gene BsmI polymorphism and bone mineral density in a population of 146 Iranian women. Cell J. 2013; 15 (1): 75-82.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jia F, Sun RF, Li QH, Wang DX, Zhao F, Li JM, et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a metaanalysis from 26 studies. Genet Test Mol Biomarkers. 2013; 17 (1): 30-34. doi: 10.1089/gtmb.2012.0267.</mixed-citation><mixed-citation xml:lang="en">Jia F, Sun RF, Li QH, Wang DX, Zhao F, Li JM, et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a metaanalysis from 26 studies. Genet Test Mol Biomarkers. 2013; 17 (1): 30-34. doi: 10.1089/gtmb.2012.0267.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Верхотурова C.B., Царенок С.Ю., Горбунов B.B., Аксенова Т.А. Полиморфизм некоторых генов метаболизма костной ткани (VDR BsmI C.IVS7G&gt;A, LCT 13910 Т&gt;С, COL1A 12046 G&gt;T) у представительниц русской и бурятской национальностей II Остеопороз и остеопатии. 2017. Т. 20, № 1. С. 3-7). doi: 10.14341/osteo201713-6.</mixed-citation><mixed-citation xml:lang="en">Verkhoturova SV, Tsarenok SU, Gorbunov W, Aksenova ТА. Polymorphism of some genes of bone tissue metabolism (VDR BsmI c.IVS7G&gt;A, LCT 13910 T&gt;C, COL1A 12046 G-&gt;T) among the representatives of Russian and Buryat nationalities. Osteoporosis and Bone Diseases. 2017; 20 (1): 3-7. Russian doi: 10.14341/osteo201713-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Тагиева A.H., Сметник В.П., Сухих Г.Т., Крылов М.Ю., Греченко А.В., Мя-коткин В.А. и др. Изучение роли генов рецептора витамина D (VDR), а-рецептора эстрогенов (ESRa) и a-1-цепи коллагена 1-го типа (COLIAI) в заболеваемости остеопорозом у женщин в постменопаузе II Медицинская генетика. 2005. Т. 4, № 2. С. 90-95.</mixed-citation><mixed-citation xml:lang="en">Tagieva AN, Smetnik VP, Suhyh GT, Krylov MU, Grechenko AV, Makotkin VA, et al. Studying the role of genes of receptor vitamin D (VDR), estrogen receptor a (ESRa) and al collagen 1 (COLIA1) in the development of postmenopausal osteoporosis. Medical Genetics. 2005; 4 (2): 90-95. Russian</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов А.И., Вершубская Г.Г., Нега-шева М.А. Полиморфизм гена рецептора витамина D (VDR) в выборках населения европейской России и Приуралья II Пермский медицинский журнал. 2016. Т. 33, № 5. С. 60-66.</mixed-citation><mixed-citation xml:lang="en">Kozlov Al, Vershubskaya GG, Negasheva MA. Polymorphism of vitamin D receptor (VDR) gene in sampling of European Russia and Priuraliye population. Perm Medical Journal. 2016; 33 (5): 60-66. Russian</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol. 2009; 169 (4): 505-514. doi: 10.1093/aje/kwn359.</mixed-citation><mixed-citation xml:lang="en">Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol. 2009; 169 (4): 505-514. doi: 10.1093/aje/kwn359.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Майлян Э.А. Влияние полиморфизма 283 A&gt;G (BsmI) гена рецептора витамина D на развитие остеопороза у женщин в постменопаузе II Медицинский вестник Юга России. 2016. № 4. С. 32-38.</mixed-citation><mixed-citation xml:lang="en">Maylyan EA. The influence of vitamin D receptor gene 283 A&gt;G (BsmI) polymorphism on osteoporosis in postmenopausal women. Medical Bulletin of the Russian South. 2016; 4: 3238. Russian</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mostowska A, Lianeri М, Wudarski М, Olesinska М, Jagodzinski РР. Vitamin D receptor gene BsmI, FokI, Apal and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep. 2013; 40 (2): 803-810. doi: 10.1007/sll033-012-2118-6.</mixed-citation><mixed-citation xml:lang="en">Mostowska A, Lianeri М, Wudarski М, Olesinska М, Jagodzinski РР. Vitamin D receptor gene BsmI, FokI, Apal and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep. 2013; 40 (2): 803-810. doi: 10.1007/sll033-012-2118-6.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Correa-Rodrfguez M, Carrillo-Avila JA, Schmidt-Rio Valle J, Gonzalez-Jimenez E, Vargas S, Martin J, et al. Genetic association analysis of vitamin D receptor gene polymorphisms and obesityrelated phenotypes. Gene. 2018; 640: 51-56. doi: 10.1016/j.gene.2017.10.029.</mixed-citation><mixed-citation xml:lang="en">Correa-Rodrfguez M, Carrillo-Avila JA, Schmidt-Rio Valle J, Gonzalez-Jimenez E, Vargas S, Martin J, et al. Genetic association analysis of vitamin D receptor gene polymorphisms and obesity-related phenotypes. Gene. 2018; 640: 51-56. doi: 10.1016/j.gene.2017.10.029.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Colombini A, Brayda-Bruno M, Lombardi G, Croiset SJ, Ceriani C, Buligan C, et al. BsmI, Apal and TaqI polymorphisms in the vitamin D receptor gene (VDR) and association with lumbar spine pathologies: an Italian case-control study. PLoS ONE. 2016; 11 (5): e0155004. doi: 10.1371/journal.pone.0155004.</mixed-citation><mixed-citation xml:lang="en">Colombini A, Brayda-Bruno M, Lombardi G, Croiset SJ, Ceriani C, Buligan C, et al. BsmI, Apal and TaqI polymorphisms in the vitamin D receptor gene (VDR) and association with lumbar spine pathologies: an Italian case-control study. PLoS ONE. 2016; 11 (5): e0155004. doi: 10.1371/journal.pone.0155004.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001; 85 (2): 171-175. doi: 10.1054/bjoc.2001.1864.</mixed-citation><mixed-citation xml:lang="en">Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001; 85 (2): 171-175. doi: 10.1054/bjoc.2001.1864.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho C, Marinho A, Leal B, Bettencourt A, Boleixa D, Almeida I, et al. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus. 2015; 24 (8): 846-853. doi: 10.1177/0961203314566636.</mixed-citation><mixed-citation xml:lang="en">Carvalho C, Marinho A, Leal B, Bettencourt A, Boleixa D, Almeida I, et al. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus. 2015; 24 (8): 846-853. doi: 10.1177/0961203314566636.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
